STAT· @statnews · X·· 23 天前精选AI 评分78
AI 导读
STAT News 报道,一项个性化 mRNA 疗法在癌症患者中改善结局的首个关键性试验于本周末公布,黑色素瘤专家的讨论已转向后续方向。报道未披露具体药物、试验数据或适应症细节。
推荐理由
该报道呈现了个性化 mRNA 疗法首个关键性试验在癌症患者中改善结局,读者可据此了解黑色素瘤治疗讨论的走向。
正文
MADRID — With the first pivotal trial showing a customized mRNA treatment improved outcomes for cancer patients presented here this weekend, the conversation has already turned to how melanoma specialists… https://trib.al/P7WcLvg
来源:STAT · x.com